SIGA Research and Charts

SIGA - SIGA Technologies Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-01-06)

Last 6.40	Change ⇑ +0.07 (+1.11%)	Volume 602,358
	Open 6.43	High 6.49	Low 6.29

8EMA (Daily) 6.18	40EMA (Daily) 6.46	50EMA (Daily) 6.57	STO (Daily) 63.042	MACD Hist (Daily) 0.132
8EMA (Weekly) 6.426	40EMA (Weekly) 7.12	50EMA (Weekly) 7.12	STO (Weekly) 18.622	MACD Hist (Weekly) -0.179


Company Profile
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.